DARPA: Harnessing Enzymatic Activity for Lifesaving Remedies (HEALR)
|קרן||US Department of Defense|
|פקולטה||Engineering, Life Sciences, Medicine|
The goal of the HEALR program is to develop new medical countermeasures against bacterial pathogens and their toxins by leveraging host degradation and deactivation pathways.
HEALR aims to develop:
(1) tools to target microbial pathogens via protein degradation (i.e., target-binding ligand development);
(2) innovative modalities to enable new pathways to protein degradation or deactivation;
(3) a platform that leverages these advances to permit flexible and rapid response to emerging threats.
Funding: No fixed limit
Duration: 54 months
Research Authority due date: 4.8.20
Abstract (strongly encouraged) due date:11.8.20
Full proposal due date: 17.9.20
|עדכון אחרון||עדכון אחרון: 28/06/2020|